K822770 is an FDA 510(k) clearance for the BURLINGTON STOCKINETTE.
Submitted by Balfour, Inc. (Mchenry, US). The FDA issued a Cleared decision on July 26, 1983 after a review of 315 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Physical Medicine FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.
View all Balfour, Inc. devices